The mitogen-activated protein kinase signaling cascade: From bench to bedside

Israel Medical Association Journal

Volumn 4, Issue 8, 2002, Pages 641-647

  Wolf, Ido ^a   Seger, Rony ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

Extracellular signal regulated kinase; Malignancy; Mitogen activated protein kinase; Signaling

Indexed keywords

2 (2 CHLORO 4 IODOANILINO) N CYCLOPROPYLMETHOXY 3,4 DIFLUOROBENZAMIDE; ANTIBODY; ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; CYTOKINE; G PROTEIN COUPLED RECEPTOR; GROWTH FACTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; HORMONE; LIGAND; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE; NEUROTRANSMITTER; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN FARNESYLTRANSFERASE INHIBITOR; PROTEIN KINASE; RAS PROTEIN; RAS PROTEIN KINASE; SYNAPTOPHYSIN; TRASTUZUMAB; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG;

ACUTE LEUKEMIA; AMINO TERMINAL SEQUENCE; APOPTOSIS; ASTHMA; AUTOPHOSPHORYLATION; BRAIN FUNCTION; BREAST CANCER; CARBOXY TERMINAL SEQUENCE; CARDIOVASCULAR DISEASE; CELL CYCLE; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CELLULAR PARAMETERS; CLINICAL TRIAL; COLON CANCER; CYTOSOL; DIABETES MELLITUS; DISEASE MODEL; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INACTIVATION; ENZYME LOCALIZATION; ENZYME STRUCTURE; HUMAN; IN VIVO STUDY; INFLUENZA; KIDNEY CARCINOMA; LEARNING; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT TRANSFORMATION; MEMORY; MITOGENESIS; NONHUMAN; OSTEOARTHRITIS; PATHOGENESIS; PROSTATE CARCINOMA; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; SOLID TUMOR; STRESS; STROKE;

APOPTOSIS; HUMANS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASMS; PROTEIN KINASES; RECEPTOR PROTEIN-TYROSINE KINASES;

EID: 0036335934     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. The MAPK signaling cascade
2. Activation of MAPK cascades by G-protein-coupled receptor: The case of gonadotropin-releasing hormone receptor
3. Mitogen-activated protein (MAP) kinase pathways: Regulation and physiological functions
4. Targeting the Ras signaling pathway: A rational, mechanism-based treatment for hematologic malignancies?
5. ERK1b: A 46 kD ERK isoform that is differentially regulated by MEK
6. Identification of a cytoplasmic retention sequence in ERK2
7. Involvement of the activation loop of ERK in the detachment from cytosolic anchoring
8. Protein phosphatase and the regulation of mitogen-activated protein kinase signaling
9. Control of the eukariotic cell cycle by MAP kinase signaling pathways
10. The role of identified neurotransmitter systems in the response of insular cortex to unfamiliar taste: Activation of ERK1-2 and formation of a memory trace
11. Mammalian MAP kinase signalling cascades
12. Constitutive activation of the 41-/43-kDa mitogen-activating protein kinase signaling in human tumors
13. Hyperexpression of mitogen-activated protein kinase in human breast cancer
14. Mitogen-activated protein kinase cascade in breast cancer
15. Potential prognostic value of mitogen-activated protein kinase activity for disease-free survival of primary breast cancer patients
16. Increased constitutive activity of mitogen-activated protein kinase and renaturable 85 kDa kinase in human-colorectal cancer
17. Analysis of signaling protein kinases in human colon or colorectal carcinomas
18. Expression and activity of mitogen activated protein kinases in human colorectal carcinoma
19. Downregulation of mitogen-activated protein kinases in human colon cancers
20. Differential regulation of MAP kinase cascade in human colorectal tumorigenesis
21. Constitutive activation of mitogen-activated protein kinase pathway in acute leukemia cells
22. Constitutive activation of extracellular signal-regulated kinase in human acute leukemias: Combined role of activation of MEK, hyperexpression of extracellular signal-regulated kinase, and downregulation of a phosphatase, PAC1
23. Activation of mitogen-activated protein kinase associated with prostate cancer progression
24. Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma
25. Mechanical stress-induced cardiac hypertrophy: Mechanisms and signal transduction pathways
26. Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation
27. Activation of mitogen-activated protein kinases in human heart during cardiopulmonary bypass
28. Thyroid hormone induces activation of mitogen-activated protein kinase in cultured cells
29. Signal transduction cascades triggered by EGF receptor activation: Relevance to gastric injury repair and ulcer healing
30. New perspectives into the molecular pathogenesis and treatment of type 2 diabetes
31. Hyperglycemia acutely increases monocyte extracellular signal-regulated kinase activity in vivo in humans
32. Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-JUN N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis
33. MAPK superfamily activation in human airway smooth muscle: Mitogenesis requires prolonged p42/p44 activation
34. Activation of MAP kinase (ERK-1/ERK-2), tyrosine kinase and VEGF in the human brain following acute ischaemic stroke
35. Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade
36. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2
37. A phase I trial of c-Raf kinase antisense oligonucleotide ISIS 5132 administered as a continuous intravenous infusion in patients with advanced cancer
38. Blockade of the MAP kinase pathway suppresses growth of colon cancer tumors in vivo
39. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: Insight into mechanisms and implications for cancer growth and ulcer healing
40. Inhibition of extracellular signal-regulated kinase 1/2 phosphorylation and induction of apoptosis by sulindac metabolites